Morphic Therapeutic

About:

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Website: http://morphictx.com/

Twitter/X: morphictx

Top Investors: Schrödinger, AbbVie, Invus, Novo Holdings, Polaris Partners

Description:

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer. The company offers the development of therapies for patients with immunological, fibrotic, neoplastic, and vascular diseases, focusing on creating small molecule inhibitors of various integrin targets.